Page last updated: 2024-09-05

3,4-dihydro-3-hydroxy-8-methoxy-3-methyl-2h-benz(a)anthracene-1,7,12-trione and staphyloxanthin

3,4-dihydro-3-hydroxy-8-methoxy-3-methyl-2h-benz(a)anthracene-1,7,12-trione has been researched along with staphyloxanthin in 1 studies

Compound Research Comparison

Studies
(3,4-dihydro-3-hydroxy-8-methoxy-3-methyl-2h-benz(a)anthracene-1,7,12-trione)
Trials
(3,4-dihydro-3-hydroxy-8-methoxy-3-methyl-2h-benz(a)anthracene-1,7,12-trione)
Recent Studies (post-2010)
(3,4-dihydro-3-hydroxy-8-methoxy-3-methyl-2h-benz(a)anthracene-1,7,12-trione)
Studies
(staphyloxanthin)
Trials
(staphyloxanthin)
Recent Studies (post-2010) (staphyloxanthin)
80368055

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukuda, T; Koyama, N; Mori, Y; Onaka, H; Sakai, K; Tomoda, H1

Other Studies

1 other study(ies) available for 3,4-dihydro-3-hydroxy-8-methoxy-3-methyl-2h-benz(a)anthracene-1,7,12-trione and staphyloxanthin

ArticleYear
Search method for inhibitors of Staphyloxanthin production by methicillin-resistant Staphylococcus aureus.
    Biological & pharmaceutical bulletin, 2012, Volume: 35, Issue:1

    Topics: Actinobacteria; Alkenes; Anthraquinones; Anti-Bacterial Agents; Benz(a)Anthracenes; Biological Products; Cerulenin; Flavonoids; Heterocyclic Compounds, 3-Ring; Lipid Metabolism; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Propiophenones; Staphylococcal Infections; Vancomycin; Xanthophylls

2012